Search Results

There are 14527 results for: content related to: Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer

  1. The TRAMP Mouse as a Model for Prostate Cancer

    Unit

    Current Protocols in Immunology

    20:20.5.1–20.5.23

    Arthur A. Hurwitz, Barbara A. Foster, James P. Allison, Norman M. Greenberg and Eugene D. Kwon

    Published Online : 1 NOV 2001, DOI: 10.1002/0471142735.im2005s45

  2. Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell

    The Prostate

    Volume 73, Issue 9, June 2013, Pages: 941–951, Roberto Benelli, Sara Stigliani, Simona Minghelli, Sebastiano Carlone and Nicoletta Ferrari

    Article first published online : 17 JAN 2013, DOI: 10.1002/pros.22640

  3. Long pentraxin-3 as an epithelial–stromal fibroblast growth factor-targeting inhibitor in prostate cancer

    The Journal of Pathology

    Volume 230, Issue 2, June 2013, Pages: 228–238, Roberto Ronca, Patrizia Alessi, Daniela Coltrini, Emanuela Di Salle, Arianna Giacomini, Daria Leali, Michela Corsini, Mirella Belleri, Chiara Tobia, Cecilia Garlanda, Elisa Bonomi, Regina Tardanico, William Vermi and Marco Presta

    Article first published online : 13 MAY 2013, DOI: 10.1002/path.4181

  4. Hexim-1 modulates androgen receptor and the TGF-β signaling during the progression of prostate cancer

    The Prostate

    Volume 72, Issue 9, 15 June 2012, Pages: 1035–1044, Eduardo J. Mascareno, Ivan Belashov, M. A. Q. Siddiqui, Fang Liu and Manya Dhar-Mascareno

    Article first published online : 9 NOV 2011, DOI: 10.1002/pros.21510

  5. Gene expression signatures associated with suppression of TRAMP prostate carcinogenesis by a kavalactone-rich Kava fraction

    Molecular Carcinogenesis

    Su-Ni Tang, Jinhui Zhang, Peixin Jiang, Palika Datta, Pablo Leitzman, M. Gerard O'Sullivan, Cheng Jiang, Chengguo Xing and Junxuan Lü

    Article first published online : 3 FEB 2016, DOI: 10.1002/mc.22469

  6. You have free access to this content
    Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)

    FEBS Letters

    Volume 485, Issue 2-3, November 24, 2000, Pages: 135–141, Allard Kaptein, Mieke Jansen, Gonul Dilaver, Jeremy Kitson, Laura Dash, Edward Wang, Michael J Owen, Jean-Luc Bodmer, Jurg Tschopp and Stuart N Farrow

    Article first published online : 21 NOV 2000, DOI: 10.1016/S0014-5793(00)02219-5

  7. Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer

    Journal of Cellular Biochemistry

    Volume 88, Issue 3, 15 February 2003, Pages: 599–608, Eddy S. Leman, Michael C. Madigan, Gisela Brünagel, Natsuki Takaha, Donald S. Coffey and Robert H. Getzenberg

    Article first published online : 11 NOV 2002, DOI: 10.1002/jcb.10368

  8. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer

    The Prostate

    Volume 75, Issue 3, February 15, 2015, Pages: 292–302, June Escara-Wilke, Jill M. Keller, Kathleen M. Woods Ignatoski, Jinlu Dai, Gregory Shelley, Atsushi Mizokami, Jian Zhang, Miranda L Yeung, Kam C. Yeung and Evan T. Keller

    Article first published online : 18 OCT 2014, DOI: 10.1002/pros.22915

  9. Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages

    The Prostate

    Volume 76, Issue 7, May 15, 2016, Pages: 624–636, Ha-Ram Cha, Joo Hyoung Lee, Jonathan A. Hensel, Anandi B. Sawant, Brittney H. Davis, Carnellia M. Lee, Jessy S. Deshane and Selvarangan Ponnazhagan

    Article first published online : 9 FEB 2016, DOI: 10.1002/pros.23155

  10. You have free access to this content
    Orthotopic treatment model of prostate cancer and metastasis in the immunocompetent mouse: Efficacy of flt3 ligand immunotherapy

    International Journal of Cancer

    Volume 107, Issue 5, 10 December 2003, Pages: 773–780, Kenneth D. Somers, Roy R. Brown, Daniel A. Holterman, Nazita Yousefieh, William F. Glass, George L. Wright Jr., Paul F. Schellhammer, Jesse Qian and Richard P. Ciavarra

    Article first published online : 29 AUG 2003, DOI: 10.1002/ijc.11464

  11. The Figure of the Tramp in Gilded Age Success Narratives

    The Journal of Popular Culture

    Volume 40, Issue 6, December 2007, Pages: 994–1018, CHRISTINE PHOTINOS

    Article first published online : 16 NOV 2007, DOI: 10.1111/j.1540-5931.2007.00482.x

  12. Indoleamine 2,3-dioxygenase (IDO) activity influence tumor growth in the TRAMP prostate cancer model

    The Prostate

    Volume 70, Issue 13, 15 September 2010, Pages: 1461–1470, Eva Källberg, Pernilla Wikström, Anders Bergh, Fredrik Ivars and Tomas Leanderson

    Article first published online : 4 MAY 2010, DOI: 10.1002/pros.21181

  13. You have free access to this content
    Peripheral T cell tolerance occurs early during spontaneous prostate cancer development and can be rescued by dendritic cell immunization

    European Journal of Immunology

    Volume 35, Issue 1, January 2005, Pages: 66–75, Elena Degl'Innocenti, Matteo Grioni, Andrea Boni, Annalisa Camporeale, Maria T. S. Bertilaccio, Massimo Freschi, Antonella Monno, Cinzia Arcelloni, Norman M. Greenberg and Matteo Bellone

    Article first published online : 14 DEC 2004, DOI: 10.1002/eji.200425531

  14. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes

    The Prostate

    Volume 75, Issue 5, April 1, 2015, Pages: 463–473, Elizabeth M. Peek, Wang Song, Hanwei Zhang, Jiaoti Huang and Arnold I. Chin

    Article first published online : 16 JAN 2015, DOI: 10.1002/pros.22932

  15. Nuclear RNA surveillance: role of TRAMP in controlling exosome specificity

    Wiley Interdisciplinary Reviews: RNA

    Volume 4, Issue 2, March/April 2013, Pages: 217–231, Karyn Schmidt and J. Scott Butler

    Article first published online : 15 FEB 2013, DOI: 10.1002/wrna.1155

  16. Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium

    The Prostate

    Volume 71, Issue 13, 15 September 2011, Pages: 1429–1440, Lei Wang, Jinhui Zhang, Yong Zhang, Katai Nkhata, Emily Quealy, Joshua D. Liao, Margot P. Cleary and Junxuan Lü

    Article first published online : 25 FEB 2011, DOI: 10.1002/pros.21360

  17. Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2

    The Prostate

    Volume 73, Issue 6, May 2013, Pages: 582–589, Aparna Gupta, Xiuping Yu, Tom Case, Manik Paul, Michael M. Shen, Klaus H. Kaestner and Robert J. Matusik

    Article first published online : 11 OCT 2012, DOI: 10.1002/pros.22598

  18. LL-37 as a therapeutic target for late stage prostate cancer

    The Prostate

    Volume 71, Issue 6, May 2011, Pages: 659–670, Jonathan A. Hensel, Diptiman Chanda, Sanjay Kumar, Anandi Sawant, William E. Grizzle, Gene P. Siegal and Selvarangan Ponnazhagan

    Article first published online : 18 OCT 2010, DOI: 10.1002/pros.21282

  19. You have full text access to this OnlineOpen article
    β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1

    Journal of Cellular Physiology

    Volume 228, Issue 7, July 2013, Pages: 1601–1609, Hira Lal Goel, Aejaz Sayeed, Michael Breen, Matthew J. Zarif, David S. Garlick, Irwin Leav, Roger J. Davis, Thomas J. FitzGerald, Andrea Morrione, Chung-Cheng Hsieh, Qin Liu, Adam P. Dicker, Dario C. Altieri and Lucia R. Languino

    Article first published online : 21 MAR 2013, DOI: 10.1002/jcp.24323

  20. Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease

    The Journal of Gene Medicine

    Volume 6, Issue 1, January 2004, Pages: 43–54, Rosetta Martiniello-Wilks, Allison Dane, Dale J. Voeks, Geetha Jeyakumar, Elin Mortensen, Jan M. Shaw, Xiao Yang Wang, Gerald W. Both and Pamela J. Russell

    Article first published online : 6 JAN 2004, DOI: 10.1002/jgm.474